Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease-Reference-Cited by-同舟云学术

Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease

Published:2011-09-30 Issue:9 Volume:6 Page:e25788
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yahata Naoki,Asai Masashi,Kitaoka Shiho,Takahashi Kazutoshi,Asaka Isao,Hioki Hiroyuki,Kaneko Takeshi,Maruyama Kei,Saido Takaomi C.,Nakahata Tatsutoshi,Asada Takashi,Yamanaka Shinya,Iwata Nobuhisa,Inoue Haruhisa

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Alzheimer's disease is a synaptic failure.;DJ Selkoe;Science,2002

2. Metabolism of amyloid-β peptide and Alzheimer's disease.;N Iwata;Pharmacol Ther,2005

3. Substrate-targeting γ-secretase modulators.;TL Kukar;Nature,2008

4. Modulation of γ-secretase reduces β-amyloid deposition in a transgenic mouse model of Alzheimer's disease.;MZ Kounnas;Neuron,2010

5. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.;K Takahashi;Cell,2007

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for modeling aging and age-related diseases;npj Aging;2024-07-10

2. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies;Cells;2024-04-25

3. Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling;Stem Cell Reviews and Reports;2024-04-02

4. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease;Cellular & Molecular Biology Letters;2023-11-30

5. Screening Station, a novel laboratory automation system for physiologically relevant cell-based assays;SLAS Technology;2023-10